Enanta Pharmaceuticals
ENTA
#7517
Rank
NZ$0.70 B
Marketcap
NZ$24.32
Share price
-1.60%
Change (1 day)
101.33%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total debt

Total debt on the balance sheet as of June 2025 : NZ$99.85 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's total debt is NZ$99.85 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Enanta Pharmaceuticals - Total debt on balance sheet (from 2014 to 2025)

Total debt by year

Year Total debt Change
2024-09-30NZ$87.41 M97.66%
2023-09-30NZ$44.22 M-1.32%
2022-09-30NZ$44.81 M480.03%
2021-09-30NZ$7.72 M-36.82%
2020-09-30NZ$12.22 M3729.08%
2019-09-30NZ$0.31 M-27.8%
2018-09-30NZ$0.44 M-16.06%
2017-09-30NZ$0.52 M-27.95%
2016-09-30NZ$0.73 M-21.86%
2015-09-30NZ$0.93 M
2014-09-30N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
AbbVie
ABBV
NZ$118.24 B 118,320.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$78.77 B 78,788.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$3.15 B 3,060.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$71.16 B 71,173.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$87.79 B 87,825.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$55.08 B 55,062.79%๐Ÿ‡จ๐Ÿ‡ญ Switzerland